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Abstract
Fifteen known type 2 diabetes (T2D) gene variants were assessed for their associations with T2D
status in 228 T2D families from the Framingham Heart Study (FHS) Original, Offspring, and
Children Cohorts. Bayesian approach was used to test single-single-nucleotide polymorphism
(SNP) association followed by logistic regression. Bayesian and logic regression approaches were
used to test multiple SNP association searching for the best combinations of variants followed by
logistic regression reconfirmation. The significant variants for T2D risk were also tested for their
main and interacting effects on triglyceride (TG)/high-density lipoprotein (HDL) ratio change
derived from four point measures across time. This slope phenotype was made available using
mixed model growth curve approach from 155 T2D families in the FHS Offspring Cohort.
Results: CDKN2B rs10811661 (p =0 . 0 4 2 ) ,TCF7L2 rs4506565 (p = 0.004), and JAZF1 rs864745
(p = 0.04) were individually associated with risk of T2D (OR = 1.0-2.0; effect size <1%). CDKN2B
and TCF7L2 were found with significant main (p = 0.02, 0.01) and interacting (p =0 . 0 5 )e f f e c t sf o r
increased (OR = 3.0) risk of T2D. CDKN2B and JAZF1 were found with significant main (p = 0.0002
and 0.034) and interacting (p = 0.001) effects on increased (b = 0.42) TG/HDL ratio longitudinal
change. These interacting effects were independent of effects of age and sex with effect sizes of
0.3-0.4% for risk of T2D or TG/HDL ratio longitudinal change.
Conclusion: These synthetic approaches allowed for successful detection of CDKN2B and TCF7L2
interacting effect for T2D risk and CDKN2B and JAZF1 interacting effect on TG/HDL ratio increase
over time among T2D families in the FHS. These interacting effects were consistent in conferring
risk of T2D or progressive insulin resistance with modest effect sizes.
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Fifteen replicated gene variants for type 2 diabetes (T2D)
have been assessed [1]. While more variants remain to be
uncovered, challenge exists in better understanding of
the interplay among these variants underneath complex
T2D pathophysiology and pathogenesis. These variants
were either common with negligible effect or rare with
relatively larger effect size [1]. In reality, it is very likely
that the individual main effect of each variant is
undetectable, but collectively their effect emerges.
Concurrent increased triglyceride (TG) and decreased
high-density lipoprotein (HDL) were characteristics of
subjects with insulin resistance, mostly seen in patients
with T2D. The inverse relationship and combined
information of these two measures, TG/HDL ratio,
represents a single inherited phenotype [2] as a surrogate
for insulin resistance [3]. In this analysis, we hypo-
thesized that multiple variants jointly confer T2D
susceptibility, and we wanted to examine main and
interacting effects of the reported variants in the Off-
spring Cohort of the Framingham Heart Study (FHS)
using different statistical analysis approaches.
Methods
Subjects
All participants in the FHS were Caucasians. Their
characteristics were described elsewhere [4]. In brief,
participants with diabetes comprised 7.59% (28/369),
9.91% (242/2,441), and 2.38% (95/3,997) of the
Original, Offspring, and Children Cohorts, respectively.
Average age of diagnosis of diabetes at study visit were
66, 57, and 46 years in the three cohorts, respectively.
From a total of 6,807 members in 1,157 families, 228
families had members with diabetes (3,217 members,
366 diabetes cases); 46% (1,489/3,217) were men. In the
Offspring Cohort, 155 families had members with
diabetes (727 members) who had valid fasting TG and
HDL measures at 4 time points. In the Offspring Cohort
families with member with diabetes, the average age was
33.8, 46.4, 53.3, and 60.2 years, average BMI was 25.2,
26.2, 27.6, and 28.3 kg/m
2, average TG was 83.7, 108.5,
134.0, and 135.5 mg/dl, average HDL was 51.6, 52.6,
51.6, and 54.5 mg/dl, and average TG/HDL ratio was 1.9,
2.5, 3.1, and 3.0, at Visit 1, 3, 5, and 7, respectively. Every
study subject provided written informed consent. The
study was approved by Boston University Institutional
Review Board.
Genotyping
Affymetrix 100 k single-nucleotide polymorphisms
(SNPs) and genotype annotation resources were
described elsewhere [4]. Identical variants or variants in
the same intron/exon regions were identified using
Affymetrix 500 k SNPs.
Statistical analysis
Covariates included age, age
2, and sex. BIMBAM (Baye-
sian imputation-based association mapping) [5] was
used to assess single-SNP effect according to Bayes Factor
(BF) and p-value (based on 10,000 permutations). This
was followed by logistic-GEE (generalized estimating
equations) single-SNP test under general and additive
assumptions. BIMBAM output corrected p for multiple
testing. BIMBAM was further used to identify the best
multiple-SNP combination with the highest BF. LOG-
REG [6] was also used to find the best multiple SNP
combination as well as parameter estimates. Findings
from these two approaches were compared. The best
interacting variants may be tested for main and interact-
ing effects using the logistic-GEE approach. Further, TG/
HDL ratios at the four visits in the families in the
Offspring Cohort with member with diabetes were used
to derive TG/HDL ratio change (slope) via the mixed
growth curve model. The mixed sandwich estimator
approach was used to assess associations between the
identified interacting variants and the slope phenotype.
Results
Single-SNP test results are presented in Table 1 (BIMBAM)
and Table 2 (logistic-GEE, general model). Three variants
were found to significant under additive assumption:
CDKN2B rs10811661 (p = 0.0011), TCF7L2 rs4506565
(p =0 . 0 0 4 3 ) ,a n dJAZF1 rs864745 (p = 0.0402). Multiple
SNP test results are also given in Table 1. LOGREG results,
consistent with the BIMBAM finding, suggested almost the
same best interacting variants. Interaction between
CDKN2B rs10811661 and TCF7L2 rs4506565 was sig-
nificantly detected using the logistic-GEE model (OR = 3.0,
p = 0.02 and 0.01 and 0.05 for main and interacting
effects). For the slope trait, single-SNP test results were
non-significant for CDKN2B rs10811661 (p = 0.4621), but
significant for TCF7L2 rs4506565 (p = 0.0379) and JAZF1
rs864745 (p = 0.0349) in the mixed sandwich estimator
additive model. Interaction between CDKN2B rs10811661
and TCF7L2 rs4506565 variants were significant (b =
1.6667, p = 0.0002, 0.0341, and 0.0012 for main and
interacting effects), and it was associated with high slope
values, which may be expressed as an increase in insulin
resistance across ages.
Discussion
Our finding of TCF7L2 intron 3 variant for T2D is in line
with a previous FHS genome-wide association study report
[7] and a good number of replicating reports across large
and independent study cohorts. Evidence of CDKN2B
near/promoter and JAZF1 intron 1 variants for T2D risk
was also found. We thought the T2D families in FHS may
contain an enriched genetic component for SNP associa-
tion assessment of T2D gene variants. Currently, functions
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TCF7L2 and other confirmed T2D genes [1], they may be
directly or indirectly involved in pancreatic b-cell failure,
insulin resistance, and lipid toxicity. Our finding of
interactions among the three variants for T2D risk was
interesting and novel, which may help disentangle under-
lying gene pathways and further our understanding of T2D
etiology and pathophysiology.
Correction for multiplicity to minimize the false-positive
declaration rate seems to be less sensitive for this
analysis for two reasons. First, we aimed to identify
and evaluate the best combination of SNPs from
confirmed T2D variants. Second, the FHS T2D status
information was obtained at the initial visit of the study,
and ‘new’ T2D cases may have remained in the ‘non-
diabetic’ control group after decades of follow-up. This
would bias our association findings towards reduction of
type 1 error. The results of BIMBAM were consistent with
those of logistic-GEE analyses for the single-SNP main
effect; likewise, BIMBAM and logic regression results for
multiple-SNP joint/interacting effect were also consis-
tent. These synthetic approaches apparently worked well
in association detection for both main and joint effects
of candidate gene variants with prior knowledge.
This 500 k SNP genotype data allowed us to examine
15 of the 18 confirmed exact variants (genotypic
imputation was not applied). While reproducibility
may be cohort-specific and sensitive to sample hetero-
geneity and size, it was a bit surprising that we could
only identify three meaningful variants. It is very
possible that this was due to the presence in the control
groups of persons with diabetes who had not received a
clinical diagnosis. We did not use a transmission-
disequilibrium test-like FBAT program for this analysis
simply because we wanted to maximize the sample size
by using all available family information. We did not
correct the data for potential effect of body max index
because obesity coexisting with T2D is very likely rooted
in the same pathway genes among most T2D patients, at
least in most Western countries.
We were excited to find that the identified interacting
variants also affected the TG/HDL ratio. Using the ROC/
AUC (receiver operator characteristic/area under the
curve) model, we found that it was an imperfect
predictor of T2D with best sensitivity and specificity of
approximately 75%. Applying a mixed growth curve
approach to model longitudinal multiple measures of
the TG/HDL ratio proved useful. The derived slope
phenotype represented the TG/HDL ratio change across
decades of observation time. This approach is advanta-
geous in handling missing data points, as well as remote
values, especially in intervention and interaction studies.
Genetic heritability of the slope phenotype was 20%,
Table 1: Search results for best single and multiple SNP associations with T2D status
Method Gene Chr Position RAF
a Bayes Factor Rank P
b
BIMBAM
rs10811661 CDKN2A/2B 9p 22124094 T, 0.82 0.978 1 0.0045
rs4506565 TCF7L2 10q 114748339 T, 0.36 0.591 2 0.0154
rs864745 JAZF1 7p 28147081 A, 0.52 0.041 3 0.0397
rs17030946 THADA 2p 43587013 T, 0.10 0.035 4 0.0771
rs7961581 TSPAN8-LGR5 12q 69949369 T, 0.70 -0.161 5 0.1298
rs10946398 CDKAL1 6p 20769013 C, 0.33 -0.284 6 0.2382
rs5215 KCNJ11 11p 17365206 C, 0.36 -0.292 7 0.0944
rs2793823 ADAM30 1p 120239241 G, 0.89 -0.366 8 0.4292
rs10282940 SLC30A8 8q 118257007 G, 0.89 -0.381 9 0.4606
rs5018648 WFS1 4p 6343719 G, 0.61 -0.457 10 0.2901
rs8050136 FTO 16q 52373776 A, 0.41 -0.457 11 0.4008
rs1801282 PPARG 3p 12368125 G, 0.11 -0.488 12 0.8047
rs564398 CDKN2A/2B 9p 22019547 G, 0.39 -0.517 13 0.5119
rs4402960 IGF2BP2 3q 186994381 G, 0.67 -0.601 14 0.4523
rs4607103 ADAMTS9 3p 64686944 C, 0.74 -0.613 15 0.8136
SNP pair 1 –– –– 1.76 1, 2 –
SNP pair 2 –– ––1.064 1, 3 –
LOGREG Gene Chr Position RAF Beta Mode
c Logic
rs864745 JAZF1 7p 28147081 A, 0.52 0.03 (tree 1) Rec and
rs10811661 CDKN2A/2B 9p 22124094 T, 0.82 0.09 (tree 2) Rec and
rs4506565 TCF7L2 10q 114748339 T, 0.36 0.09 (tree 2) Dom and
rs5215 KCNJ11 11p 17365206 C, 0.36 0.09 (tree 2) Dom or
aRAF, risk allele and frequency.
bPermutation-based p-values for single-SNP association tests with T2D status using BIMBAM.
cRec, recessive coding; Dom, dominant coding.
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tively associated with an increase of the slope phenotype.
Previously, it was thought that the TCF7L2 variant was
only associated with b-cell function failure but not
insulin resistance [1]. Our current finding suggests that
TCF7L2, together with JAZF1 variants, may indirectly
impart insulin resistance through joint modulation of
lipid metabolism.
In conclusion, using the FHS T2D family data and
different statistical approaches, we found variants in the
TCF7L2, CDKN2B,a n dJAZF1 genes were independently
and interactively associated with increased T2D risk and
the TG/HDL ratio change across ages. For the remaining
T2D risk conferring gene variants, we did not find
significant association evidence in this analysis.
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